Sana Biotechnology, Inc. SANA
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-02-04
Sana Biotechnology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 11,045,448 | $60.3M | 4.14% |
| MILLENNIUM MANAGEMENT LLC | 1,591,030 | $4.6M | 0.6% |
| RENAISSANCE TECHNOLOGIES LLC | 1,451,200 | $4.2M | 0.54% |
| TWO SIGMA INVESTMENTS, LP | 1,198,579 | $3.5M | 0.45% |
| AQR CAPITAL MANAGEMENT LLC | 1,124,279 | $3.2M | 0.42% |
| CITADEL ADVISORS LLC | 769,790 | $2.2M | 0.29% |
| D. E. Shaw & Co., Inc. | 38,670 | $111,369 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.